Stephen D. Barrett,James B. Kramer,Mark L. Boys,Huifen Chen
申请号：
US13864457
公开号：
US09090625B2
申请日:
2013.04.17
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention provides for compounds of Formula I, and pharmaceutically acceptable salts thereof,wherein R1, R2, R3, R4, R5, R6, and R7 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as therapeutic agents in the treatment of TGFβ-mediated conditions, including cancer and fibrotic disorders. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
